|
Market Closed -
Other stock markets
|
After hours 03:59:59 pm | |||
| 163.70 EUR | +2.06% |
|
163.35 | -0.21% |
| Jul. 24 | Healthcare Shares Benefit From Rotation Away From AI Darlings -- Health Care Roundup | DJ |
| Jul. 24 | Ipsen Provides Update On Phase III BOLD Trial In Biliary Atresia | CI |
Company Valuation: Ipsen
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,621 | 8,279 | 8,912 | 9,155 | 9,770 | 13,422 | - | - |
| Change | - | 25.05% | 7.65% | 2.72% | 6.72% | 37.38% | - | - |
| Enterprise Value (EV) 1 | 6,758 | 7,894 | 8,860 | 9,020 | 9,225 | 12,077 | 11,075 | 10,288 |
| Change | - | 16.81% | 12.22% | 1.81% | 2.28% | 30.91% | -8.29% | -7.11% |
| P/E | 10.4x | 12.9x | 14x | 26.7x | 22.4x | 14.9x | 14.5x | 14.4x |
| PBR | 2.42x | - | 2.36x | 2.22x | 2.3x | 2.68x | 2.28x | 1.97x |
| PEG | - | 20.02x | -13.67x | -0.6x | 0.8x | 0x | 5.88x | 21.06x |
| Capitalization / Revenue | 2.31x | 2.74x | 2.85x | 2.69x | 2.49x | 3.11x | 2.96x | 2.83x |
| EV / Revenue | 2.36x | 2.61x | 2.83x | 2.65x | 2.35x | 2.8x | 2.45x | 2.17x |
| EV / EBITDA | 5.8x | 5.86x | 10.1x | 7.52x | 6.67x | 7.21x | 6.59x | 6.17x |
| EV / EBIT | 6.68x | 7.08x | 8.85x | 8.13x | 7.13x | 8.3x | 7.53x | 7.01x |
| EV / FCF | 8.31x | 9.02x | 12.5x | 11.6x | 8.93x | 10.2x | 9.31x | 8.5x |
| FCF Yield | 12% | 11.1% | 8.02% | 8.59% | 11.2% | 9.76% | 10.7% | 11.8% |
| Dividend per Share 2 | 1.2 | 1.2 | 1.2 | 1.4 | 1.4 | 1.518 | 1.532 | 1.663 |
| Rate of return | 1.49% | 1.19% | 1.11% | 1.26% | 1.18% | 0.93% | 0.94% | 1.02% |
| EPS 2 | 7.76 | 7.81 | 7.73 | 4.15 | 5.32 | 10.99 | 11.26 | 11.34 |
| Distribution rate | 15.5% | 15.4% | 15.5% | 33.7% | 26.3% | 13.8% | 13.6% | 14.7% |
| Net sales 1 | 2,869 | 3,025 | 3,128 | 3,401 | 3,929 | 4,311 | 4,527 | 4,743 |
| EBITDA 1 | 1,166 | 1,348 | 881.4 | 1,200 | 1,383 | 1,675 | 1,681 | 1,667 |
| EBIT 1 | 1,011 | 1,115 | 1,001 | 1,109 | 1,294 | 1,456 | 1,470 | 1,469 |
| Net income 1 | 646.6 | 647.5 | 647.2 | 347.3 | 444.5 | 939.6 | 953.7 | 955 |
| Net Debt 1 | 137.8 | -384.7 | -52.9 | -134.9 | -544.5 | -1,345 | -2,347 | -3,134 |
| Reference price 2 | 80.50 | 100.50 | 107.90 | 110.70 | 119.00 | 163.70 | 163.70 | 163.70 |
| Nbr of stocks (in thousands) | 82,243 | 82,380 | 82,599 | 82,700 | 82,100 | 81,990 | - | - |
| Announcement Date | 2/11/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 14.6x | 2.74x | 7.05x | 0.95% | 14.99B | ||
| 36.25x | 12.94x | 27.18x | 0.55% | 1,089B | ||
| 28.59x | 6.53x | 18.09x | 2.01% | 643B | ||
| 33.13x | 7.75x | 15.94x | 2.61% | 465B | ||
| 20.2x | 4.86x | 12.04x | 2.72% | 359B | ||
| 22.65x | 5.84x | 14.57x | 2.74% | 303B | ||
| 22.03x | 4.53x | 12.8x | 1.93% | 267B | ||
| 14.79x | 5.48x | 11.3x | 3.38% | 226B | ||
| 25.81x | 6.73x | 11.86x | 2.57% | 212B | ||
| -48.4x | 5.8x | 32.01x | 2.45% | 167B | ||
| Average | 16.97x | 6.32x | 16.29x | 2.19% | 374.61B | |
| Weighted average by Cap. | 25.15x | 8.09x | 19.04x | 1.91% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IPN Stock
- Valuation Ipsen
Select your edition
All financial news and data tailored to specific country editions
















